Clorox (NYSE:CLX) Price Target Lowered to $108.00 at TD Cowen

Clorox (NYSE:CLX) had its price target decreased by TD Cowen from $117.00 to $108.00 in a report released on Thursday,Benzinga reports. TD Cowen currently has a hold rating on the stock.

Other equities research analysts also recently issued reports about the company. JPMorgan Chase & Co. decreased their price target on Clorox from $127.00 to $120.00 and set a “neutral” rating for the company in a report on Tuesday, November 4th. Jefferies Financial Group restated a “buy” rating and issued a $152.00 target price on shares of Clorox in a research note on Tuesday, November 4th. Bank of America dropped their price target on shares of Clorox from $135.00 to $125.00 and set a “neutral” rating on the stock in a research note on Wednesday, October 8th. The Goldman Sachs Group cut their price target on shares of Clorox from $110.00 to $94.00 and set a “sell” rating for the company in a report on Wednesday. Finally, Wells Fargo & Company lowered their price objective on Clorox from $117.00 to $108.00 and set an “equal weight” rating on the stock in a report on Monday. One equities research analyst has rated the stock with a Buy rating, fourteen have assigned a Hold rating and four have issued a Sell rating to the stock. Based on data from MarketBeat.com, Clorox currently has an average rating of “Reduce” and a consensus price target of $122.88.

Clorox Price Performance

Shares of NYSE:CLX opened at $104.24 on Thursday. Clorox has a one year low of $96.66 and a one year high of $164.22. The stock has a market capitalization of $12.72 billion, a price-to-earnings ratio of 16.36, a PEG ratio of 0.50 and a beta of 0.58. The company has a 50-day simple moving average of $103.13 and a 200-day simple moving average of $115.78. The company has a debt-to-equity ratio of 18.01, a quick ratio of 0.50 and a current ratio of 0.76.

Clorox (NYSE:CLX) last issued its quarterly earnings results on Monday, November 3rd. The company reported $0.85 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.78 by $0.07. The firm had revenue of $1.43 billion for the quarter, compared to analysts’ expectations of $1.41 billion. Clorox had a return on equity of 358.39% and a net margin of 11.68%.The firm’s revenue for the quarter was down 18.9% on a year-over-year basis. During the same quarter in the previous year, the firm posted $1.86 EPS. Clorox has set its FY 2026 guidance at 5.950-6.300 EPS. On average, analysts predict that Clorox will post 7.15 EPS for the current year.

Clorox Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, February 13th. Stockholders of record on Wednesday, January 28th will be paid a dividend of $1.24 per share. This represents a $4.96 dividend on an annualized basis and a dividend yield of 4.8%. The ex-dividend date of this dividend is Wednesday, January 28th. Clorox’s dividend payout ratio (DPR) is 77.86%.

Insider Activity

In related news, Director Pierre R. Breber bought 4,000 shares of Clorox stock in a transaction that occurred on Friday, November 21st. The shares were purchased at an average price of $104.13 per share, with a total value of $416,520.00. Following the purchase, the director owned 13,000 shares in the company, valued at $1,353,690. This represents a 44.44% increase in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available through this link. 0.63% of the stock is owned by corporate insiders.

Institutional Trading of Clorox

A number of large investors have recently made changes to their positions in CLX. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. boosted its stake in shares of Clorox by 4.0% during the 1st quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 13,380 shares of the company’s stock worth $1,970,000 after purchasing an additional 514 shares during the last quarter. Goldman Sachs Group Inc. grew its stake in Clorox by 147.6% in the 1st quarter. Goldman Sachs Group Inc. now owns 707,005 shares of the company’s stock worth $104,107,000 after acquiring an additional 421,453 shares during the period. Caxton Associates LLP purchased a new stake in Clorox in the 1st quarter worth approximately $580,000. Empowered Funds LLC raised its holdings in Clorox by 109.9% in the 1st quarter. Empowered Funds LLC now owns 46,534 shares of the company’s stock valued at $6,852,000 after acquiring an additional 24,360 shares during the last quarter. Finally, Woodline Partners LP lifted its stake in shares of Clorox by 253.7% during the 1st quarter. Woodline Partners LP now owns 10,407 shares of the company’s stock worth $1,532,000 after purchasing an additional 7,465 shares during the period. Institutional investors and hedge funds own 78.53% of the company’s stock.

About Clorox

The Clorox Company is a leading manufacturer and marketer of consumer and professional products designed to help people care for their homes and live healthy, sustainable lives. Its portfolio spans cleaning and household products, food and beverages, water filtration systems and cat litter, serving both retail and institutional customers. The company’s flagship bleach and disinfecting products are well known in the United States and many international markets, where they help prevent the spread of germs in homes, hospitals, schools and businesses.

Clorox’s diverse brand lineup includes liquid bleach and surface cleaners, eco-friendly cleaning tools, food preservation and preparation items, charcoal grills and briquettes, specialty foods and beverages, pet care products and personal care lines.